Cargando…

Correction: Development of a systemic lupus erythematosus cardiovascular risk equation

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046966/ https://www.ncbi.nlm.nih.gov/pubmed/32153797 http://dx.doi.org/10.1136/lupus-2019-000346corr1

Ejemplares similares

Development of a systemic lupus erythematosus cardiovascular risk equation
por: Petri, Michelle A, et al.
Publicado: (2019)

Correction to: The Patient Experience of Fatigue in Systemic Lupus Erythematosus: A Conceptual Model
por: Cleanthous, Sophie, et al.
Publicado: (2021)

Erratum: Cardiovascular events prior to or early after diagnosis of systemic lupus erythematosus in the systemic lupus international collaborating clinics cohort
Publicado: (2016)

Correction: Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus
por: Shah, Kamini, et al.
Publicado: (2010)

Correction: Biomarkers of erosive arthritis in systemic lupus erythematosus: Application of machine learning models
por: Ceccarelli, Fulvia, et al.
Publicado: (2019)

Correction to: Circulating exosomes from patients with systemic lupus erythematosus induce an proinflammatory immune response
por: Lee, Joo Youn, et al.
Publicado: (2020)

Correction: Lipid Anti-Lipid Antibody Responses Correlate with Disease Activity in Systemic Lupus Erythematosus
por: Jovanović, Vojislav, et al.
Publicado: (2013)

Correction to: Identification of key biomarkers and immune infiltration in systemic lupus erythematosus by integrated bioinformatics analysis
por: Zhao, Xingwang, et al.
Publicado: (2021)

Risk Factors in Cardiovascular Disease in Systemic Lupus Erythematosus
por: Sinicato, Nailú Angélica, et al.
Publicado: (2013)

Systemic lupus erythematosus and cardiovascular disease
por: Ruilope, Luis M., et al.
Publicado: (2020)

Systemic Lupus Erythematosus and Cardiovascular Disease
por: Jha, Surajkumar B, et al.
Publicado: (2022)

Cardiovascular Complications in Systemic Lupus Erythematosus
por: Alghareeb, Rahmah, et al.
Publicado: (2022)

Cardiovascular Disease in Systemic Lupus Erythematosus
por: McMahon, Maureen, et al.
Publicado: (2021)

Systemic lupus erythematosus and cardiovascular disease
por: Frostegård, Johan
Publicado: (2022)

Correction: Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus
por: Dörner, Thomas, et al.
Publicado: (2008)

Correction: Significant Reductions in Mortality in Hospitalized Patients with Systemic Lupus Erythematosus in Washington State from 2003 to 2011
por: Goss, Louisa B, et al.
Publicado: (2015)

Correction to: Evaluating the performance of ACR, SLICC and EULAR/ACR classification criteria in childhood onset systemic lupus erythematosus
por: Abdwani, Reem, et al.
Publicado: (2021)

Correction: Population-based prevalence and incidence estimates of primary discoid lupus erythematosus from the Manhattan Lupus Surveillance Program
Publicado: (2019)

Correction: Cluster of systemic lupus erythematosus (SLE) associated with an oil field waste site: a cross sectional study
por: Dahlgren, James, et al.
Publicado: (2007)

Correction: Pregnancy outcomes in patients receiving assisted reproductive therapy with systemic lupus erythematosus: a multi-center retrospective study
por: Lao, Minxi, et al.
Publicado: (2023)

Cardiovascular Disease in Systemic Lupus Erythematosus: The Role of Traditional and Lupus Related Risk Factors
por: Zeller, Carlos Borelli, et al.
Publicado: (2008)

Sclerostin as a biomarker of cardiovascular risk in women with systemic lupus erythematosus
por: Garcia-de los Ríos, Carlos, et al.
Publicado: (2022)

Correction to: Phase 2, randomized, placebo-controlled trial of dapirolizumab pegol in patients with moderate-to-severe active systemic lupus erythematosus
Publicado: (2022)

Author Correction: A phenotypic and genomics approach in a multi-ethnic cohort to subtype systemic lupus erythematosus
por: Lanata, Cristina M., et al.
Publicado: (2020)

Development and validation of limited sampling strategy equation for mycophenolate mofetil in children with systemic lupus erythematosus
por: Prabha, R., et al.
Publicado: (2016)

Correction: Steady-state mycophenolate mofetil pharmacokinetic parameters enable prediction of systemic lupus erythematosus clinical flares: an observational cohort study
por: Djabarouti, Sarah, et al.
Publicado: (2011)

Correction: Defective Expression and Function of the Leukocyte Associated Ig-like Receptor 1 in B Lymphocytes from Systemic Lupus Erythematosus Patients
por: Colombo, Barbara M., et al.
Publicado: (2012)

Correction: Gene Network Analysis of Bone Marrow Mononuclear Cells Reveals Activation of Multiple Kinase Pathways in Human Systemic Lupus Erythematosus
por: Nakou, Magdalene, et al.
Publicado: (2013)

Assessment of cardiovascular risk tools as predictors of cardiovascular disease events in systemic lupus erythematosus
por: Sivakumaran, Jagan, et al.
Publicado: (2021)

Correction: The influence of intrathecal injection of methotrexate and dexamethasone on neuropsychiatric systemic lupus erythematosus (NPSLE): a retrospective cohort study of 386 patients with NPSLE
por: Nie, Yuxue, et al.
Publicado: (2023)

Correction: Belimumab for Treating Active Autoantibody‑Positive Systemic Lupus Erythematosus: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
por: Otten, Thomas, et al.
Publicado: (2023)

Correction: Genetic Variants of IκB Kinase β (IKBKB) and Polymerase β (POLB) Were Not Associated with Systemic Lupus Erythematosus Risk in a Chinese Han Population
por: Li, Yuan, et al.
Publicado: (2015)

Correction: Deconvolution of whole blood transcriptomics identifies changes in immune cell composition in patients with systemic lupus erythematosus (SLE) treated with mycophenolate mofetil
por: Akthar, Mumina, et al.
Publicado: (2023)

The interplay of inflammation and cardiovascular disease in systemic lupus erythematosus
por: Kahlenberg, J Michelle, et al.
Publicado: (2011)

Imaging Assessment of Cardiovascular Disease in Systemic Lupus Erythematosus
por: Croca, Sara C., et al.
Publicado: (2012)

New developments in systemic lupus erythematosus
por: Tsang-A-Sjoe, Michel W. P., et al.
Publicado: (2021)

Non-traditional risk and protective factors for cardiovascular disease in systemic lupus erythematosus
por: Cederholm, A, et al.
Publicado: (2005)

Systemic Lupus Erythematosus and Cardiovascular Diseases: A Systematic Review
por: Nor, Mohammed A, et al.
Publicado: (2023)

Correction: Vitamin K-dependent proteins GAS6 and Protein S and TAM receptors in patients of systemic lupus erythematosus: correlation with common genetic variants and disease activity
por: Recarte-Pelz, Pedro, et al.
Publicado: (2014)

Correction to: How can we accurately measure disease activity during pregnancy in systemic lupus erythematosus? New insights from the BILAG-2004 Pregnancy Index
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v0oscgc3c00vds72mhti7f4jn8